Year |
Citation |
Score |
2016 |
Liu H, Li W, Yu X, Gao F, Duan Z, Ma X, Tan S, Yuan Y, Liu L, Wang J, Zhou X, Yang Y. EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis. Oncotarget. PMID 27472460 DOI: 10.18632/oncotarget.10841 |
0.342 |
|
2016 |
Zhang LD, Liu Z, Liu H, Ran DM, Guo JH, Jiang B, Wu YL, Gao FH. Oridonin enhances the anticancer activity of NVP-BEZ235 against neuroblastoma cells in vitro and in vivo through autophagy. International Journal of Oncology. PMID 27278249 DOI: 10.3892/ijo.2016.3557 |
0.325 |
|
2010 |
Papageorgis P, Lambert AW, Ozturk S, Gao F, Pan H, Manne U, Alekseyev YO, Thiagalingam A, Abdolmaleky HM, Lenburg M, Thiagalingam S. Smad signaling is required to maintain epigenetic silencing during breast cancer progression. Cancer Research. 70: 968-78. PMID 20086175 DOI: 10.1158/0008-5472.Can-09-1872 |
0.668 |
|
2009 |
Gao F, Ponte JF, Levy M, Papageorgis P, Cook NM, Ozturk S, Lambert AW, Thiagalingam A, Abdolmaleky HM, Sullivan BA, Thiagalingam S. hBub1 negatively regulates p53 mediated early cell death upon mitotic checkpoint activation. Cancer Biology & Therapy. 8: 548-56. PMID 19252416 DOI: 10.4161/Cbt.8.7.7929 |
0.706 |
|
2009 |
Gao F, Ponte JF, Papageorgis P, Levy M, Ozturk S, Lambert AW, Pan H, Chinnappan D, Cheng KH, Thiagalingam A, Abdolmaleky HM, Thiagalingam S. hBub1 deficiency triggers a novel p53 mediated early apoptotic checkpoint pathway in mitotic spindle damaged cells. Cancer Biology & Therapy. 8: 627-35. PMID 19242126 DOI: 10.4161/Cbt.8.7.7928 |
0.624 |
|
2007 |
Pan H, Gao F, Papageorgis P, Abdolmaleky HM, Faller DV, Thiagalingam S. Aberrant activation of gamma-catenin promotes genomic instability and oncogenic effects during tumor progression. Cancer Biology & Therapy. 6: 1638-43. PMID 18245958 DOI: 10.4161/Cbt.6.10.4904 |
0.714 |
|
2006 |
Abdolmaleky HM, Cheng KH, Faraone SV, Wilcox M, Glatt SJ, Gao F, Smith CL, Shafa R, Aeali B, Carnevale J, Pan H, Papageorgis P, Ponte JF, Sivaraman V, Tsuang MT, et al. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Human Molecular Genetics. 15: 3132-45. PMID 16984965 DOI: 10.1093/Hmg/Ddl253 |
0.636 |
|
Show low-probability matches. |